Compare DUOT & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOT | ANGO |
|---|---|---|
| Founded | 1990 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.0M | 420.2M |
| IPO Year | 2017 | 2004 |
| Metric | DUOT | ANGO |
|---|---|---|
| Price | $8.14 | $13.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $17.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 816.0K | 536.0K |
| Earning Date | 05-14-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.96 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $27,023,651.00 | ★ $291,010,000.00 |
| Revenue This Year | $50.98 | $9.51 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 271.16 | 10.17 |
| 52 Week Low | $5.78 | $8.36 |
| 52 Week High | $15.28 | $15.20 |
| Indicator | DUOT | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 34.08 | 54.96 |
| Support Level | $7.97 | $13.02 |
| Resistance Level | $8.61 | $13.76 |
| Average True Range (ATR) | 0.61 | 0.67 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 5.09 | 42.29 |
Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.